rational
pneumonia
lead
caus
mortal
infant
young
children
mechan
lead
mortal
children
poorli
understood
studi
cellular
immunolog
infant
airway
tradit
hinder
limit
sampl
volum
avail
young
frail
children
admit
hospit
pneumonia
compound
rel
low
frequenc
certain
immun
cell
phenotyp
thought
critic
clinic
outcom
pneumonia
address
develop
novel
insilico
deconvolut
method
infer
frequenc
immun
cell
phenotyp
airway
children
differ
surviv
outcom
use
proteom
data
method
use
highresolut
mass
spectrometri
identifi
protein
express
airway
children
admit
hospit
clinic
pneumonia
children
discharg
hospit
surviv
day
discharg
die
admiss
use
machin
learn
random
forest
deriv
protein
featur
could
use
deconvolv
immun
cell
phenotyp
paediatr
airway
sampl
appli
phenotypespecif
signatur
identifi
airwayresid
immun
cell
phenotyp
differenti
enrich
surviv
statu
valid
find
use
larg
retrospect
pneumonia
cohort
identifi
immunecel
phenotyp
classif
featur
immun
cell
type
eosinophilassoci
featur
significantli
elev
airway
sampl
obtain
pneumonia
survivor
downregul
children
subsequ
die
confirm
result
analyz
clinic
paramet
doi
biorxiv
preprint
result
retrospect
analysi
mirror
airway
deconvolut
data
show
survivor
significantli
elev
eosinophil
admiss
compar
fatal
pneumonia
use
proteom
bioinformat
approach
identifi
airway
eosinophil
critic
factor
pneumonia
surviv
infant
young
children
doi
biorxiv
preprint
nasopharyng
oropharyng
swab
sampl
obtain
children
centrifug
minut
l
supernat
remov
discard
remain
split
two
aliquot
first
aliquot
use
neutrophil
phenotyp
assay
use
neutrophil
phagocytosi
assay
preconstitut
cocktail
follow
antibodi
thermofish
use
label
aliquot
hladr
livedead
marker
except
livedead
marker
antibodi
dilut
fac
buffer
livedead
marker
prepar
dilut
fac
buffer
phagocytosi
assay
tube
l
opsonis
escherichia
coli
ecoli
ad
tube
phrodo
red
e
coli
bioparticl
thermofish
bacteria
initi
prepar
mix
ecoli
strain
newborn
calf
sera
follow
incub
c
step
tube
incub
c
minut
incub
l
livedead
marker
ad
tube
incub
minut
c
reaction
stop
ad
l
rbc
lysi
buffer
follow
incub
cell
tube
spun
minut
supernat
discard
cell
wash
twice
fac
buffer
l
fac
flow
ad
cell
analys
immedi
bd
lsr
fortessa
instrument
follow
gate
strategi
use
detect
airwayresid
neutrophil
debri
exclud
basi
forward
fsca
side
ssca
scatter
characterist
doublet
exclud
use
fsca
versu
fsch
dead
cell
exclud
use
livedead
marker
pneumonia
lead
caus
paediatr
mortal
wordwid
recent
studi
global
burden
paediatr
pneumonia
conduct
seven
countri
found
virus
account
paediatr
pneumonia
infect
infect
attribut
bacteri
pathogen
rsv
account
largest
etiolog
fraction
paediatr
pneumonia
death
occur
due
pneumonia
children
occur
low
resourc
set
mainli
due
lack
paediatr
intens
care
facil
young
infant
especi
comorbid
hiv
malnutrit
poor
surviv
prognosi
follow
pneumonia
infect
hivinfect
infant
develop
pneumonia
infect
time
like
die
infect
nonhiv
infect
children
malnutrit
time
like
die
admiss
damag
lung
caus
sever
pneumonia
appear
persist
even
discharg
hospit
recent
estim
show
postdischarg
mortal
african
children
previous
admit
hospit
pneumonia
eight
time
greater
discharg
diagnos
differ
immunolog
respons
pneumonia
children
succumb
infect
surviv
clear
improv
understand
immunobiolog
elev
post
infect
mortal
risk
crucial
identifi
prognost
biomark
poor
outcom
critic
guid
care
decis
first
critic
hour
admiss
studi
mechan
sever
pneumonia
infant
done
use
blood
sampl
whist
studi
provid
signific
insight
diseas
patholog
might
fulli
recapitul
immun
respons
infect
airway
case
rsv
one
studi
last
year
examin
lung
sampl
children
die
pneumonia
archiv
postmortem
lung
tissu
three
children
die
preintensivist
era
usa
evalu
airway
obstruct
necrot
cell
fibrin
mucu
fluid
identifi
promin
featur
rsv
lung
infect
stain
immun
cell
popul
technic
feasibl
long
term
archiv
sampl
due
pauciti
mechanist
data
immunolog
respons
pneumonia
airway
broad
interest
understand
dynam
airwayresid
immun
cell
follow
pneumonia
infect
infant
effort
hinder
unsuit
routin
airway
sampl
techniqu
convent
cytometr
analys
sampl
nasopharyng
wash
nasoand
oropharyng
swab
common
method
sampl
airway
sick
children
whilst
ideal
molecular
diagnost
less
suitabl
phenotyp
airway
resid
immun
cell
use
convent
cytometri
techniqu
sampl
airway
method
typic
result
limit
cell
yield
cell
recov
gener
highli
enrich
granulocyt
complic
detail
characteris
less
abund
phenotyp
use
tradit
flow
cytometrybas
tool
recent
analysi
cellular
composit
upper
airway
flow
cytometri
show
typic
abund
critic
effector
cell
like
cell
b
cell
mast
cell
dendrit
cell
nk
cell
less
airway
cell
granulocyt
present
median
frequenc
potenti
way
address
shortcom
monitor
chang
marker
protein
uniqu
predominantli
express
specif
immun
cell
phenotyp
use
inform
infer
dynam
underli
cell
type
recent
describ
highresolut
massspectrometrybas
proteom
approach
character
total
proteom
infant
airway
depth
protein
airway
proteom
character
techniqu
repres
unbias
snapshot
underli
cell
popul
leverag
infer
chang
frequenc
contribut
cell
phenotyp
describ
insilico
immun
cell
phenotyp
deconvolut
approach
use
protein
marker
uniqu
predominantli
express
specif
immun
cell
subset
infer
dynam
phenotyp
airway
children
surviv
die
pneumonia
phenotypeclassif
featur
deriv
previous
publish
data
set
contain
individu
proteom
purifi
immun
cell
popul
deconvolut
data
set
appli
airway
proteom
data
children
differ
pneumonia
outcom
figur
contain
graphic
descript
studi
design
use
inform
identifi
eosinophilrel
protein
signatur
elev
airway
children
surviv
pneumonia
downregul
fatal
pneumonia
well
control
subsequ
valid
associ
use
larg
retrospect
pneumonia
cohort
children
determin
whether
deconvolut
proteom
data
set
contain
suffici
resolut
distinguish
individu
immun
cell
phenotyp
use
protein
express
level
data
set
visualis
phenotyp
segreg
nonmetr
multidimension
scale
nmd
analysi
show
major
immun
cell
phenotyp
includ
bcell
cell
natur
killer
nk
cell
dendrit
cell
dc
monocyt
mo
basophil
eosinophil
neutrophil
could
distinctli
segreg
basi
differenti
protein
express
figur
set
identifi
individu
protein
could
use
accur
distinguish
major
sub
immun
phenotyp
sub
phenotyp
defin
lowerlevel
hierarchi
major
phenotyp
eg
plasmacytoid
myeloid
dc
within
major
dc
phenotyp
within
deconvolut
data
set
use
recurs
featur
eliminationpair
random
forest
rf
algorithm
boruta
identifi
classif
featur
major
sub
immun
cell
phenotyp
supplementari
tabl
sinc
subset
featur
protein
like
express
within
specif
context
inflam
airway
set
determin
featur
identifi
model
also
express
airway
children
admit
pneumonia
cell
type
monocytesmacrophag
neutrophil
substanti
proport
phenotyp
classif
featur
featur
select
model
also
express
airway
other
eg
nk
cell
lower
proport
classifi
next
undertook
detail
analysi
phenotyp
classif
featur
identifi
machin
learn
determin
whether
could
use
recapitul
phenotyp
unsupervis
predict
analysi
reason
classif
featur
particular
phenotyp
would
broadli
relat
function
properti
subject
independ
unsupervis
enrich
analysi
would
success
predict
phenotyp
initi
deriv
use
unsupervis
enrich
platform
enrichr
enhanc
power
identifi
featur
resolv
constitu
cell
phenotyp
complex
sampl
gener
phenotyp
classif
profil
classif
featur
particular
phenotyp
aggreg
combin
express
plot
rel
phenotyp
exampl
analysi
shown
figur
combin
express
monocytespecif
featur
plot
red
compar
express
level
protein
phenotyp
plot
gray
result
analysi
show
protein
express
significantli
higher
level
monocyt
compar
phenotyp
p
similar
analysi
phenotyp
present
supplementari
figur
use
tsne
dimension
reduct
analysi
visualis
segreg
major
sub
phenotyp
basi
phenotyp
classif
featur
figur
result
analysi
show
featur
classifi
protein
could
clearli
distinguish
immun
cell
type
phenotyp
like
plasma
cell
bplasma
pdc
mdc
eosinophil
basophil
neutrophil
differ
monocyt
sub
phenotyp
clearli
distinguish
rest
phenotyp
subphenotyp
central
memori
cell
effector
memori
cell
could
clearli
disaggreg
basi
featur
express
alon
appli
phenotyp
classif
featur
identifi
machin
learn
airway
proteom
data
obtain
nasooropharyng
sampl
children
admit
hospit
clinic
pneumonia
either
surviv
discharg
hospit
ultim
die
cours
admiss
also
obtain
similar
data
agematch
well
control
sampl
commun
use
fals
discoveri
rate
fdr
identifi
protein
airway
children
compar
express
level
phenotypespecif
featur
protein
group
found
express
level
eosinophilspecif
classif
featur
significantli
overexpress
children
surviv
infect
rel
nonsurvivor
p
control
figur
contrast
neutrophil
express
level
phenotypespecif
protein
vari
surviv
statu
figur
express
level
protein
predominantli
express
cell
also
significantli
elev
pneumonia
survivor
compar
nonsurvivor
p
observ
signific
differ
remain
phenotyp
figur
valid
find
review
clinic
record
children
admit
kilifi
counti
hospit
kenya
approxim
period
clinic
pneumonia
haematolog
data
includ
eosinophil
neutrophil
count
collect
admiss
data
stratifi
surviv
statu
differ
eosinophil
neutrophil
count
group
test
found
eosinophil
count
children
surviv
pneumonia
retrospect
valid
cohort
significantli
greater
nonsurvivor
figur
first
panel
evalu
risk
mortal
first
day
admiss
subset
children
elev
risk
pneumonia
mortal
undernourish
children
order
determin
associ
eosinophil
count
pneumonia
surviv
group
eosinophil
count
group
stratifi
two
group
basi
median
count
undernourish
children
admit
pneumonia
low
median
eosinophil
count
significantli
like
die
first
day
admiss
rel
high
eosinophil
count
figur
second
panel
contrast
associ
mortal
observ
neutrophil
analys
use
similar
strategi
figur
report
new
method
deconvolv
immun
cell
popul
resid
airway
infant
children
differ
surviv
outcom
sever
pneumonia
studi
mucos
cellular
immun
sever
pneumonia
hinder
number
import
hurdl
includ
low
sampl
volum
well
rel
low
abund
immun
cell
phenotyp
may
critic
direct
clinic
cours
pneumonia
studi
address
problem
use
machin
learn
approach
identifi
protein
marker
could
use
deconvolv
mix
immun
cell
appli
marker
airway
proteom
data
obtain
children
differ
surviv
outcom
clinic
pneumonia
result
show
protein
marker
associ
eosinophil
elev
airway
survivor
diminish
children
later
die
infect
airway
level
eosinophil
marker
differ
children
die
well
control
suggest
failur
mount
appropri
eosinophil
respons
potenti
mechan
pneumoniarel
mortal
especi
high
risk
popul
undernourish
children
valid
find
airway
proteom
analysi
review
hospitalis
record
children
admit
hospit
previou
year
clinic
pneumonia
result
retrospect
analysi
confirm
observ
made
analysi
airway
proteom
show
children
die
pneumonia
significantli
lower
blood
eosinophil
count
rel
surviv
contrast
neutrophil
level
differ
survivor
non
survivor
airway
proteom
retrospect
valid
cohort
previou
studi
shown
eosinophil
activ
airway
shortli
pneumonia
infect
appear
contribut
significantli
airway
recoveri
increas
express
eosinophilrel
marker
children
sever
pneumonia
associ
reduc
requir
supplement
oxygen
suggest
cell
critic
compon
host
respons
infect
pathogen
airway
airwayresid
eosinophil
extens
characteris
previou
pneumonia
studi
although
protein
express
predominantli
eosinophil
includ
leukotrien
eosinophilderiv
neurotoxin
eosinophil
cation
protein
ecp
express
high
level
viral
pneumonia
taken
togeth
result
current
studi
appear
clear
role
eosinophil
respons
pneumonia
infect
failur
suffici
recruit
airway
may
signific
factor
mortal
potenti
limit
studi
carri
use
sampl
collect
upper
airway
lung
lung
sampl
would
undoubtedli
inform
respons
site
diseas
collect
sampl
highli
invas
process
expos
children
substanti
addit
risk
without
provid
addit
diagnost
valu
nasopharyng
peripher
blood
sampl
result
sampl
gener
avail
set
paediatr
intens
care
facil
even
gener
collect
children
atyp
sever
diseas
addit
eosinophil
previou
studi
shown
infect
caus
sever
pneumonia
rsv
trigger
strong
cellular
respons
characteris
influx
innat
immun
cell
initi
respons
infect
characteris
airway
recruit
neutrophil
express
marker
itgam
neutrophil
granul
protein
neutrophil
elastas
elan
innat
immun
cell
nk
cell
express
granzym
b
recruit
lower
airway
detect
lung
mechanicallyventil
children
sever
pneumonia
addit
cell
myeloid
plasmacytoid
dendrit
cell
typic
recruit
airway
children
pneumonia
earli
stage
infect
exhibit
activ
proinflammatori
phenotyp
adapt
immun
cell
includ
cell
present
airway
sampl
children
viral
pneumonia
infect
airway
frequenc
granzym
bsecret
activ
cell
greater
airway
children
sever
viral
pneumonia
present
studi
found
protein
marker
differ
phenotyp
cell
significantli
elev
airway
children
surviv
pneumonia
rel
die
well
control
although
data
avail
valid
phenotyp
retrospect
cohort
data
suggest
role
cell
pneumonia
surviv
previou
studi
mechan
ventil
children
show
frequenc
lungassoci
cell
increas
children
recov
infect
suggest
cell
import
compon
effect
local
immun
pneumonia
deficit
airway
children
pneumonia
signific
risk
factor
mortal
summari
present
data
identifi
new
approach
characteris
cellular
immun
respons
pneumonia
airway
identifi
critic
immun
popul
appear
critic
surviv
futur
studi
aim
replic
find
sampl
collect
lower
respiratori
tract
studi
recruit
infant
children
admit
kilifi
counti
hospit
clinic
pneumonia
defin
use
world
health
organis
syndrom
criteria
nasoand
oropharyng
swab
sampl
centrifug
min
obtain
cell
pellet
wash
use
pb
lyse
beadvortex
minut
cell
lysi
buffer
rlt
qiagen
germani
protein
well
dna
rna
extract
lysat
use
allprep
dnarnaprotein
mini
kit
qiagen
germani
follow
manufactur
instruct
concentr
total
protein
obtain
determin
use
bradford
assay
biorad
usa
thirti
microgram
total
protein
sampl
reduc
tri
phosphin
tcep
sigmaaldrich
usa
subsequ
alkyl
iaa
sigmaaldrich
usa
minut
room
temperatur
keep
reaction
protect
light
protein
precipit
overnight
six
volum
prechil
aceton
sigmaaldrich
usa
sampl
centrifug
minut
obtain
protein
pellet
supernat
discard
protein
pellet
resuspend
triethylammonium
bicarbon
teab
sigmaaldrich
usa
trypsin
sigmaaldrich
usa
ad
protein
sampl
trypsinprotein
sampl
ratio
protein
digest
allow
proceed
overnight
shake
peptid
sampl
randomli
assign
individu
batch
contain
nine
patient
sampl
one
pool
control
sampl
pool
control
sampl
consist
pool
peptid
patient
sampl
peptid
sampl
deriv
individu
patient
individu
label
use
mass
tag
kit
thermo
scientif
usa
accord
manufactur
instruct
one
isobar
tag
exclus
use
label
pool
control
sampl
label
peptid
subsequ
combin
gener
individu
pool
label
peptid
pool
desalt
use
pipett
ziptip
millipor
usa
accord
manufactur
instruct
elut
peptid
dri
speedvac
concentr
thermo
scientif
usa
peptid
load
use
dionex
ultim
nanoflow
ultrahighpressur
liquid
chromatographi
system
thermo
scientif
usa
x
cm
trap
column
thermo
scientif
usa
separ
x
cm
reversephas
analyt
column
thermo
scientif
heat
lfq
protein
quantif
elut
carri
mobil
phase
b
acetonitril
formic
acid
gradient
min
flow
rate
lc
run
finish
washout
b
min
reequilibr
b
min
five
blank
min
run
column
inject
compris
two
wash
cycl
b
equilibr
phase
min
avoid
sampl
carryov
peptid
measur
use
q
exact
orbitrap
mass
spectromet
thermo
scientif
usa
coupl
chromatographi
system
via
nanoelectrospray
ion
sourc
thermo
scientif
q
exact
set
peptid
resolut
agc
target
maximum
ms
scan
rang
mz
set
fragment
spectra
peptid
resolut
label
peptid
agc
target
maximum
ms
isol
window
mz
ms
data
acquir
data
depend
acquisit
top
label
peptid
intens
precursor
ion
posit
mode
select
higherenergi
ctrap
dissoci
fragment
subsequ
exclud
next
follow
fragment
event
charg
exclus
set
ignor
peptid
spectrum
match
unassign
singli
charg
charg
raw
mass
spectromet
file
analys
maxquant
softwar
version
search
human
uniprot
fasta
databas
elut
peptid
dri
speedvac
concentr
thermo
scientif
usa
peptid
load
use
dionex
ultim
nanoflow
ultrahighpressur
liquid
chromatographi
system
thermo
scientif
usa
x
cm
trap
column
thermo
scientif
usa
separ
x
cm
reversephas
analyt
column
thermo
scientif
heat
lfq
protein
quantif
elut
carri
mobil
phase
b
acetonitril
formic
acid
gradient
min
flow
rate
lc
run
finish
washout
b
min
reequilibr
b
min
five
blank
min
run
column
inject
compris
two
wash
cycl
b
equilibr
phase
min
avoid
sampl
carryov
peptid
measur
use
q
exact
orbitrap
mass
spectromet
thermo
scientif
usa
coupl
chromatographi
system
via
nanoelectrospray
ion
sourc
thermo
scientif
q
exact
set
peptid
resolut
agc
target
maximum
ms
scan
rang
mz
set
fragment
spectra
peptid
resolut
label
peptid
agc
target
maximum
ms
isol
window
mz
ms
data
acquir
data
depend
acquisit
top
label
peptid
intens
precursor
ion
posit
mode
select
higherenergi
ctrap
dissoci
fragment
subsequ
exclud
next
follow
fragment
event
charg
exclus
set
ignor
peptid
spectrum
match
unassign
singli
charg
charg
raw
mass
spectromet
file
analys
maxquant
softwar
version
search
human
uniprot
fasta
databas
download
februari
use
andromeda
search
engin
data
analyz
r
deconvolut
analysi
random
forest
classif
done
use
boruta
packag
maximum
iter
protein
classifi
whose
mean
express
test
phenotyp
significantli
greater
altern
phenotyp
taken
forward
analysi
tsne
analysi
carri
use
rtsne
iter
paramet
set
maximum
perplex
valu
analysi
carri
two
dimension
space
cell
type
enrich
analysi
done
one
enrichr
platform
input
search
term
use
enrich
analysi
rf
protein
classifi
list
deriv
random
forest
classif
pairwis
comparison
express
level
rf
classifi
phenotyp
frequenc
immun
cell
type
surviv
state
done
use
ttest
normalis
data
deconvolut
data
set
use
identifi
phenotypespecif
protein
classifi
obtain
previous
publish
paper
rieckmann
et
al
proteom
data
report
paper
avail
proteomexchang
consortium
databas
access
number
silico
deconvolut
analysi
base
high
resolut
mass
spectrometri
data
obtain
airway
cell
obtain
naso
oropharyng
site
use
separ
swab
elut
common
transport
media
shown
sampl
contain
broad
divers
immun
cell
includ
tcell
monocytesmacrophag
neutrophil
cell
isol
sampl
centrifug
process
mass
spectrometri
analysi
use
standard
protocol
see
method
c
silico
phenotyp
deconvolut
conduct
initi
identifi
phenotyp
specif
protein
featur
previouslypublish
deconvolut
data
set
use
random
forest
featur
select
featur
appli
airway
proteom
data
set
obtain
children
admit
hospit
sever
pneumonia
use
construct
detail
map
airway
immunophenotyp
associ
clinic
outcom
visual
separ
immun
cell
phenotyp
major
phenotyp
level
base
protein
express
data
deconvolut
data
set
observ
express
profil
certain
cell
type
includ
neutrophil
monocyt
basophil
result
clear
separ
immun
cell
type
identifi
specif
protein
could
use
distinguish
phenotyp
use
random
forest
featur
select
use
approach
identifi
protein
featur
phenotyp
could
use
disaggreg
individu
phenotyp
complex
mixtur
supplementari
tabl
gabarap
gnaq
gusb
hltf
lyz
mtfmt
ncstn
pam
vcan
airway
express
level
report
intens
surviv
probabl
high
low
either
surviv
discharg
die
admiss
pneumonia
survivor
significantli
greater
eosinophil
count
admiss
compar
nonsurvivor
second
panel
subset
children
acut
undernourish
admiss
defin
midupp
arm
muac
circumfer
children
stratifi
two
group
basi
median
eosinophil
count
first
day
admiss
children
whose
eosinophil
count
median
like
die
rel
abovemedian
count
b
contrast
associ
neutrophil
count
surviv
statu
